ZA942970B - Pyrido(1,2,3-de)quinoxaline derivatives, process for their production and their use in pharmaceutical agents. - Google Patents
Pyrido(1,2,3-de)quinoxaline derivatives, process for their production and their use in pharmaceutical agents.Info
- Publication number
- ZA942970B ZA942970B ZA942970A ZA942970A ZA942970B ZA 942970 B ZA942970 B ZA 942970B ZA 942970 A ZA942970 A ZA 942970A ZA 942970 A ZA942970 A ZA 942970A ZA 942970 B ZA942970 B ZA 942970B
- Authority
- ZA
- South Africa
- Prior art keywords
- pct
- production
- pharmaceutical agents
- quinoxaline derivatives
- pyrido
- Prior art date
Links
- 239000008177 pharmaceutical agent Substances 0.000 title abstract 2
- 125000001567 quinoxalinyl group Chemical class N1=C(C=NC2=CC=CC=C12)* 0.000 title abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- -1 -POXY Inorganic materials 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4314593A DE4314593A1 (de) | 1993-04-28 | 1993-04-28 | Pyrido(1,2,3-de)chinoxalinderivate, Verfahren zu deren Herstellung und ihre Verwendung von Arzneimitteln |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA942970B true ZA942970B (en) | 1995-01-19 |
Family
ID=6487060
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA942970A ZA942970B (en) | 1993-04-28 | 1994-04-28 | Pyrido(1,2,3-de)quinoxaline derivatives, process for their production and their use in pharmaceutical agents. |
Country Status (22)
Country | Link |
---|---|
US (1) | US5750526A (no) |
EP (1) | EP0696291B1 (no) |
JP (1) | JPH09500359A (no) |
KR (1) | KR960701885A (no) |
CN (1) | CN1043576C (no) |
AT (1) | ATE169925T1 (no) |
AU (1) | AU686160B2 (no) |
CA (1) | CA2161427A1 (no) |
CZ (1) | CZ277795A3 (no) |
DE (2) | DE4314593A1 (no) |
DK (1) | DK0696291T3 (no) |
ES (1) | ES2122274T3 (no) |
FI (1) | FI955141A0 (no) |
HU (1) | HUT74173A (no) |
IL (1) | IL109396A (no) |
NO (1) | NO305439B1 (no) |
NZ (1) | NZ265600A (no) |
PL (1) | PL174418B1 (no) |
RU (1) | RU2140924C1 (no) |
SK (1) | SK131995A3 (no) |
WO (1) | WO1994025472A1 (no) |
ZA (1) | ZA942970B (no) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0903144A4 (en) * | 1996-04-17 | 2001-10-31 | Sumitomo Pharma | MEDICINE FOR RETINAL NEUROPATHY |
US6063774A (en) * | 1996-12-16 | 2000-05-16 | Warner-Lambert Company | Tricyclic quinoxaline derivatives as neuroprotective agents |
CN113620890B (zh) * | 2020-05-07 | 2024-06-28 | 普济生物科技(台州)有限公司 | 苯并喹喔啉酮化合物及其合成方法和用途 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2955358B2 (ja) * | 1989-06-09 | 1999-10-04 | ファルマシア・アンド・アップジョン・カンパニー | 中枢神経系活性を有する複素環系アミン |
US5273975A (en) * | 1989-06-09 | 1993-12-28 | The Upjohn Company | Heterocyclic amines having central nervous system activity |
JPH05117276A (ja) * | 1991-10-23 | 1993-05-14 | Sumitomo Pharmaceut Co Ltd | 新規な3環性キノキサリンジオン誘導体 |
-
1993
- 1993-04-28 DE DE4314593A patent/DE4314593A1/de not_active Withdrawn
-
1994
- 1994-04-22 IL IL109396A patent/IL109396A/xx not_active IP Right Cessation
- 1994-04-28 DE DE59406739T patent/DE59406739D1/de not_active Expired - Lifetime
- 1994-04-28 KR KR1019950704707A patent/KR960701885A/ko not_active Application Discontinuation
- 1994-04-28 HU HU9502810A patent/HUT74173A/hu unknown
- 1994-04-28 CZ CZ952777A patent/CZ277795A3/cs unknown
- 1994-04-28 AT AT94914314T patent/ATE169925T1/de not_active IP Right Cessation
- 1994-04-28 PL PL94311295A patent/PL174418B1/pl unknown
- 1994-04-28 NZ NZ265600A patent/NZ265600A/en unknown
- 1994-04-28 ZA ZA942970A patent/ZA942970B/xx unknown
- 1994-04-28 WO PCT/DE1994/000494 patent/WO1994025472A1/de not_active Application Discontinuation
- 1994-04-28 SK SK1319-95A patent/SK131995A3/sk unknown
- 1994-04-28 RU RU95119828A patent/RU2140924C1/ru active
- 1994-04-28 AU AU66756/94A patent/AU686160B2/en not_active Ceased
- 1994-04-28 CN CN94191912A patent/CN1043576C/zh not_active Expired - Fee Related
- 1994-04-28 US US08/535,250 patent/US5750526A/en not_active Expired - Fee Related
- 1994-04-28 DK DK94914314T patent/DK0696291T3/da active
- 1994-04-28 ES ES94914314T patent/ES2122274T3/es not_active Expired - Lifetime
- 1994-04-28 CA CA002161427A patent/CA2161427A1/en not_active Abandoned
- 1994-04-28 JP JP6523752A patent/JPH09500359A/ja active Pending
- 1994-04-28 EP EP94914314A patent/EP0696291B1/de not_active Expired - Lifetime
-
1995
- 1995-10-27 NO NO954317A patent/NO305439B1/no unknown
- 1995-10-27 FI FI955141A patent/FI955141A0/fi unknown
Also Published As
Publication number | Publication date |
---|---|
DE59406739D1 (de) | 1998-09-24 |
ATE169925T1 (de) | 1998-09-15 |
JPH09500359A (ja) | 1997-01-14 |
HUT74173A (en) | 1996-11-28 |
HU9502810D0 (en) | 1995-11-28 |
PL311295A1 (en) | 1996-02-05 |
ES2122274T3 (es) | 1998-12-16 |
DK0696291T3 (da) | 1999-05-25 |
EP0696291A1 (de) | 1996-02-14 |
WO1994025472A1 (de) | 1994-11-10 |
CN1043576C (zh) | 1999-06-09 |
IL109396A (en) | 1997-11-20 |
DE4314593A1 (de) | 1994-11-03 |
AU686160B2 (en) | 1998-02-05 |
KR960701885A (ko) | 1996-03-28 |
PL174418B1 (pl) | 1998-07-31 |
NZ265600A (en) | 1996-09-25 |
AU6675694A (en) | 1994-11-21 |
NO954317L (no) | 1995-12-28 |
RU2140924C1 (ru) | 1999-11-10 |
SK131995A3 (en) | 1996-07-03 |
FI955141A (fi) | 1995-10-27 |
NO954317D0 (no) | 1995-10-27 |
FI955141A0 (fi) | 1995-10-27 |
IL109396A0 (en) | 1994-07-31 |
CA2161427A1 (en) | 1994-11-10 |
CN1121720A (zh) | 1996-05-01 |
NO305439B1 (no) | 1999-05-31 |
US5750526A (en) | 1998-05-12 |
CZ277795A3 (en) | 1996-02-14 |
EP0696291B1 (de) | 1998-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE51231T1 (de) | Pyrimidopyrimidinderivate, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische zubereitungen und ihre verwendung als antiallergische mittel. | |
MX9605128A (es) | Nuevos derivados de aminoacidos, procedimientos para su preparacion y composiciones farmaceuticas que contienen estos compuestos. | |
CA2118704A1 (en) | Fused Tricyclic Nitrogen Containing Heterocycles as Substance P Receptor Antagonists | |
PL338181A1 (en) | Novel chemical compounds | |
TR200002380T2 (tr) | Yeni triazolo (4,5-d) pirimidin bileşikleri | |
CA2244777A1 (en) | 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors | |
AU1367497A (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma | |
ZA942970B (en) | Pyrido(1,2,3-de)quinoxaline derivatives, process for their production and their use in pharmaceutical agents. | |
ES8504189A1 (es) | Un compuesto de pirazol (3,4-b) piridina. | |
AU693241B2 (en) | New 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and use as medicaments | |
AU2001261707A1 (en) | Pirazino '1$m(1)2$m(1) :1, 6! pyrido '3,4-b! indole derivatives | |
IL112588A (en) | 2-Substituted imidazo Ú1,2-a¾ quinoxalin-4(5h)-one derivatives their preparation and pharmaceutical compositions containing them | |
ATE288910T1 (de) | Substituierte alkylaminopyridazinonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
ATE212634T1 (de) | Metalloproteaseinhibitoren, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
NO973242L (no) | Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av idiopatisk eller fysiologisk gynekomasti | |
BG108423A (en) | Dihydroimidazo[5,1-a]beta-carboline derivatives, method for preparing same and use thereof as medicine | |
HUP0002132A2 (hu) | Új arilpiperazinilalkil-3(2H)-piridazinon-vegyületek, eljárás előállításukra és hatóanyagként ilyen vegyületeket tartalmazó készítmények | |
ATE254608T1 (de) | Substituierte 2,3-benzodiazepinderivate, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische präparate sowie ihre verwendung | |
AU1370895A (en) | 2'-deoxy-5-fluorouridine derivative, pharmaceutically acceptable salt thereof, process for producing the same, and antitumor drug | |
MX9705390A (es) | Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de desordenes degenerativos cerebrales. | |
MX9705379A (es) | Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis vasodilatadora. |